Common active targeting nano drug delivery systems for cervical cancer

doi:10.3760/cma.j.cn371439-20200527-00012

Abstract

Abstract:

Cervical cancer active targeting nano drug delivery system delivers drug-loaded nanoparticles to cancer cells in a targeted way through specific ligand-receptor interaction, which has the advantages of reducing adverse drug reactions and improving drug efficacy. It is of great significance to understand the active targeting nano drug delivery system for cervical cancer to explore new carriers, drugs and targets.

Key words: Uterine cervical neoplasms, Nanoparticles, Molecular targeting treatment

Ding Xuchao, Cao Lili. Common active targeting nano drug delivery systems for cervical cancer[J]. Journal of International Oncology, 2021, 48(1): 61-64.

References 32

[1]	李雷, 吴鸣, 杨佳欣, 等. 卵巢上皮性癌和子宫颈癌患者铂类药物超敏反应的临床分析[J]. 中华妇产科杂志, 2016,51(11):825-831. DOI: 10.3760/cma.j.issn.0529-567X.2016.11.005.
[2]	Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug deli-very, therapeutics, diagnostics and imaging[J]. Nanomedicine, 2012,8(2):147-166. DOI: 10.1016/j.nano.2011.05.016. doi: 10.1016/j.nano.2011.05.016 pmid: 21703993
[3]	Dockery L, Daniel MC. Dendronized systems for the delivery of chemotherapeutics[J]. Adv Cancer Res, 2018,139:85-120. DOI: 10.1016/bs.acr.2018.04.003. doi: 10.1016/bs.acr.2018.04.003 pmid: 29941108
[4]	Zhang R, Liu Q, Liao Q, et al. CD59: a promising target for tumor immunotherapy[J]. Future Oncol, 2018,14(8):781-791. DOI: 10.2217/fon-2017-0498. pmid: 29521526
[5]	高美华, 王冰, 王丽娜, 等. CD59基因突变与肿瘤免疫逃逸信号转导的相关性研究[C]. 第九届全国免疫学学术大会论文集, 2014.
[6]	Liu Q, Huang Y, Zhang R, et al. Medical application of spirulina platensis derived C-phycocyanin[J]. Evid Based Complement Alternat Med, 2016,2016:7803846. DOI: 10.1155/2016/7803846. doi: 10.1155/2016/7803846 pmid: 27293463
[7]	Yang P, Li B, Yin QF, et al. Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells[J]. Tumour Biol, 2017,39(3):1010428317692267. DOI: 10.1177/1010428317692267. doi: 10.1177/1010428317692267 pmid: 28347253
[8]	Jiang L, Wang Y, Zhu F, et al. Molecular mechanism of anti-cancer activity of the nano-drug C-PC/CMC-CD59sp NPs in cervical cancer[J]. J Cancer, 2019,10(1):92-104. DOI: 10.7150/jca.27462. doi: 10.7150/jca.27462 pmid: 30662529
[9]	Talekar M, Kendall J, Denny W, et al. Targeting of nanoparticles in cancer: drug delivery and diagnostics[J]. Anticancer Drugs, 2011,22(10):949-962. DOI: 10.1097/CAD.0b013e32834a4554. pmid: 21970851
[10]	Xu L, Bai Q, Zhang X, et al. Folate-mediated chemotherapy and diagnostics: an updated review and outlook[J]. J Control Release, 2017,252:73-82. DOI: 10.1016/j.jconrel.2017.02.023. pmid: 28235591
[11]	Wang X, Li D, Ghali L, et al. Therapeutic potential of delivering arsenic trioxide into HPV-infected cervical cancer cells using liposomal nanotechnology[J]. Nanoscale Res Lett, 2016,11(1):94. DOI: 10.1186/s11671-016-1307-y. pmid: 26887578
[12]	Pattni BS, Chupin VV, Torchilin VP. New developments in liposo-mal drug delivery[J]. Chem Rev, 2015,115(19):10938-10966. DOI: 10.1021/acs.chemrev.5b00046. doi: 10.1021/acs.chemrev.5b00046 pmid: 26010257
[13]	Akhtar A, Ghali L, Wang SX, et al. Optimisation of folate-mediated liposomal encapsulated arsenic trioxide for treating HPV-positive cervical cancer cells in vitro[J]. Int J Mol Sci, 2019,20(9):2156. DOI: 10.3390/ijms20092156. doi: 10.3390/ijms20092156
[14]	Ji J, Zuo P, Wang YL. Enhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles[J]. Nanoscale Res Lett, 2015,10(1):453. DOI: 10.1186/s11671-015-1162-2. doi: 10.1186/s11671-015-1162-2 pmid: 26608536
[15]	You L, Liu X, Fang Z, et al. Synjournal of multifunctional Fe₃O₄@PLGA-PEG nano-niosomes as a targeting carrier for treatment of cervical cancer[J]. Mater Sci Eng C Mater Biol Appl, 2019,94:291-302. DOI: 10.1016/j.msec.2018.09.044. doi: 10.1016/j.msec.2018.09.044 pmid: 30423711
[16]	Zhang G, Liu F, Jia E, et al. Folate-modified, cisplatin-loaded li-pid carriers for cervical cancer chemotherapy[J]. Drug Deliv, 2016,23(4):1393-1397. DOI: 10.3109/10717544.2015.1054052. pmid: 26165422
[17]	Chen Y, Qu D, Fu R, et al. A Tf-modified tripterine-loaded coix seed oil microemulsion enhances anti-cervical cancer treatment[J]. Int J Nanomedicine, 2018,13:7275-7287. DOI: 10.2147/IJN.S182475. pmid: 30510417
[18]	Vithani K, Jannin V, Pouton CW, et al. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs[J]. Adv Drug Deliv Rev, 2019,142:16-34. DOI: 10.1016/j.addr.2019.01.008. pmid: 30677448
[19]	Yu J, Hsu CH, Huang CC, et al. Development of therapeutic Au-methylene blue nanoparticles for targeted photodynamic therapy of cervical cancer cells[J]. ACS Appl Mater Interfaces, 2015,7(1):432-441. DOI: 10.1021/am5064298. doi: 10.1021/am5064298 pmid: 25494339
[20]	Liu T, Liu Y, Bao X, et al. Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway[J]. PLoS One, 2013,8(9):e75864. DOI: 10.1371/journal.pone.0075864. doi: 10.1371/journal.pone.0075864 pmid: 24086649
[21]	Grabowska-Jadach I, Kalinowska D, Drozd M, et al. Synjournal, characterization and application of plasmonic hollow gold nanoshells in a photothermal therapy—new particles for theranostics[J]. Biomed Pharmacother, 2019,111:1147-1155. DOI: 10.1016/j.biopha.2019.01.037. doi: 10.1016/j.biopha.2019.01.037 pmid: 30841428
[22]	Liu T, Tian J, Chen Z, et al. Anti-TROP2 conjugated hollow gold nanospheres as a novel nanostructure for targeted photothermal destruction of cervical cancer cells[J]. Nanotechnology, 2014,25(34):345103. DOI: 10.1088/0957-4484/25/34/345103. doi: 10.1088/0957-4484/25/34/345103 pmid: 25102337
[23]	Akbarzadeh Khiavi M, Safary A, Barar J, et al. Multifunctional nanomedicines for targeting epidermal growth factor receptor in colo-rectal cancer[J]. Cell Mol Life Sci, 2020,77(6):997-1019. DOI: 10.1007/s00018-019-03305-z. pmid: 31563999
[24]	Zhou G, Wilson G, Hebbard L, et al. Aptamers: a promising che-mical antibody for cancer therapy[J]. Oncotarget, 2016,7(12):13446-13463. DOI: 10.18632/oncotarget.7178. doi: 10.18632/oncotarget.7178 pmid: 26863567
[25]	Chen Y, Wang J, Wang J, et al. Aptamer functionalized cisplatin-albumin nanoparticles for targeted delivery to epidermal growth factor receptor positive cervical cancer[J]. J Biomed Nanotechnol, 2016,12(4):656-666. DOI: 10.1166/jbn.2016.2203. doi: 10.1166/jbn.2016.2203 pmid: 27301192
[26]	Maiti S, Paira P. Biotin conjugated organic molecules and proteins for cancer therapy: a review[J]. Eur J Med Chem, 2018,145:206-223. DOI: 10.1016/j.ejmech.2018.01.001. doi: 10.1016/j.ejmech.2018.01.001 pmid: 29324341
[27]	Wang F, Ma J, Wang KS, et al. Blockade of TNF-α-induced NF-κB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone Ⅰ[J]. Int Immunopharmacol, 2015,28(1):764-772. DOI: 10.1016/j.intimp.2015.08.003. doi: 10.1016/j.intimp.2015.08.003 pmid: 26283590
[28]	Cai Y, Zhang W, Chen Z, et al. Recent insights into the biological activities and drug delivery systems of tanshinones[J]. Int J Nanomedicine, 2016,11:121-130. DOI: 10.2147/IJN.S84035. pmid: 26792989
[29]	Luo J, Meng X, Su J, et al. Biotin-modified polylactic- co-glycolic acid nanoparticles with improved antiproliferative activity of 15,16-dihydrotanshinone Ⅰ in human cervical cancer cells[J]. J Agric Food Chem, 2018,66(35):9219-9230. DOI: 10.1021/acs.jafc.8b02698. doi: 10.1021/acs.jafc.8b02698 pmid: 30102527
[30]	Vannini A, Leoni V, Barboni C, et al. αvβ3 -integrin regulates PD-L1 expression and is involved in cancer immune evasion[J]. Proc Natl Acad Sci U S A, 2019,116(40):20141-20150. DOI: 10.1073/pnas.1901931116. pmid: 31527243
[31]	Rohrbeck A, Holtje M, Adolf A, et al. The Rho ADP-ribosylating C3 exoenzyme binds cells via an Arg-Gly-Asp motif[J]. J Biol Chem, 2017,292(43):17668-17680. DOI: 10.1074/jbc.M117.798231. pmid: 28882889
[32]	Yi Y, Kim HJ, Mi P, et al. Targeted systemic delivery of siRNA to cervical cancer model using cyclic RGD-installed unimer polyion complex-assembled gold nanoparticles[J]. J Control Release, 2016,244(Pt B):247-256. DOI: 10.1016/j.jconrel.2016.08.041. doi: 10.1016/j.jconrel.2016.08.041 pmid: 27590214